Feb 1, 2020 · Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer.
Aggressive prostate cancer risk in BRCA2 mutation carriers may vary according to the specific BRCA2 mutation inherited by the at-risk individual.
These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive ...
Sep 1, 2020 · "Re: Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness." The Journal of Urology, 204(3), pp ...
Feb 1, 2020 · Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated ...
People also ask
Are BRCA1 and BRCA2 genes associated with prostate cancer?
What percentage of male patients with prostate cancer have a BRCA1 or BRCA2 mutation?
What is the association between cancer development and the BRCA1 and BRCA2 genes?
What do the genes BRCA1 and BRCA2 increase the risk of?
These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. SIGNIFICANCE: Aggressive ...
Nov 18, 2019 · These results demonstrate that specific BRCA2 PSVs may be associated with elevated risk of developing aggressive prostate cancer. Significance ...
Mutations of BRCA1/2 and other DNA damage repair genes have been associated with an increased risk of aggressive and lethal prostate cancers. In this elegant ...
Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer. We evaluated whether PSVs in ...
Nov 13, 2019 · Pathogenic sequence variants (PSV) in BRCA1 or BRCA2 (BRCA1/2) are associated with increased risk and severity of prostate cancer.